Mixed-genotypes infections with hepatitis C virus in hemodialysis subjects

Medical Journal of Malaysia

Volumn 67, Issue 2, 2012, Pages 199-203

  Hairul Aini, H ^a   Mustafa, M I A ^a   Seman, M R ^b   Nasuruddin, B A ^a  

^a INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

^b HOSPITAL TENGKU AMPUAN AFZAN   (Malaysia)

Author keywords

Hemodialysis; Hepatitis C virus; Mixed genotype infection

Indexed keywords

5' UNTRANSLATED REGION; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENOTYPE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALAYSIA; MALE; MIXED INFECTION; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PHYLOGENY; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; CLINICAL TRIAL; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; MULTICENTER STUDY; RENAL REPLACEMENT THERAPY; VIROLOGY;

BASE SEQUENCE; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALAYSIA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PREVALENCE; RENAL DIALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84866444153     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Johnson DW, Dent H, Yao Q, et al. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol Dial Transplant 2009; 24(5): 1598-603.
2. Simmonds P, Bukh J, Combet C, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42(4): 962-73.
3. Katsoulidou A, Paraskevis D, Kalapothaki V, et al. Molecular epidemiology of a hepatitis C virus outbreak in a haemodialysis unit. Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Nephrol Dial Transplant 1999; 14(5): 1188-94.
4. Ross RS, Viazov S, Clauberg R, et al. Lack of de novo hepatitis C virus infections and absence of nosocomial transmissions of GB virus C in a large cohort of German haemodialysis patients. J Viral Hepat 2009; 16(4): 230-8.
5. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3(2): 41-6.
6. Yu ML, Chuang WL. Treatment of chronic hepatitis C in Asia: when East meets West. J Gastroenterol Hepatol 2009; 24(3): 336-45.
7. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008; 48(1): 148-62.
8. Martell M, Esteban JI, Quer J, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992; 66(5): 3225-9.
9. Chen YD, Liu MY, Yu WL, et al. Mix-infections with different genotypes of HCV and with HCV plus other hepatitis viruses in patients with hepatitis C in China. World J Gastroenterol 2003; 9(5): 984-92.
10. Hu YW, Balaskas E, Furione M, et al. Comparison and application of a novel genotyping method, semiautomated primer-specific and mispair extension analysis, and four other genotyping assays for detection of hepatitis C virus mixed-genotype infections. J Clin Microbiol 2000; 38(8): 2807-13.
11. Antonishyn NA, Ast VM, McDonald RR, et al. Rapid genotyping of hepatitis C virus by primer-specific extension analysis. J Clin Microbiol 2005; 43(10): 5158-63.
12. Prescott LE, Berger A, Pawlotsky JM, Conjeevaram P, Pike I, Simmonds P. Sequence analysis of hepatitis C virus variants producing discrepant results with two different genotyping assays. J Med Virol 1997; 53(3): 237-44.
13. Tuveri R, Rothschild C, Pol S, et al. Hepatitis C virus genotypes in French haemophiliacs: kinetics and reappraisal of mixed infections. J Med Virol 1997; 51(1): 36-41.
14. Tanimoto T, Nguyen HC, Ishizaki A, et al. Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam. J Med Virol 2010; 82(8): 1355-63.
15. Viazov S, Widell A, Nordenfelt E. Mixed infection with two types of hepatitis C virus is probably a rare event. Infection 2000; 28(1): 21-5.
16. Chakravarti A, Verma V. Distribution of hepatitis C virus genotypes in beta-thalassaemic patients from Northern India. Transfus Med 2006; 16(6): 433-8.
17. Tanimoto T, Nguyen HC, Ishizaki A, et al. Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam. J Med Virol 2010; 82(8): 1355-63.
18. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995;171(6): 1607-10.
19. Sistayanarain A, Kunthalert D, Vipsoongnern Y. A shift in the Hepatitis C virus genotype dominance in blood donor samples from Thailand. Mol Biol Rep 2010: 27.
20. Chow WC, Ng HS, Hepatitis C, E and G virus--three new viruses identified by molecular biology technique in the last decade. Ann Acad Med Singapore 1997; 26(5): 682-6.
21. Alfaresi MS. Prevalence of hepatitis C virus (HCV) genotypes among positive UAE patients. Mol Biol Rep; 2010: 20.
22. Giannini C, Giannelli F, Monti M, et al. Prevalence of mixed infection by different hepatitis C virus genotypes in patients with hepatitis C virus-related chronic liver disease. J Lab Clin Med 1999; 134(1): 68-73.
23. Qian KP, Natov SN, Pereira BJ, Lau JY. Hepatitis C virus mixed genotype infection in patients on haemodialysis. J Viral Hepat 2000; 7(2): 153-60.
24. Carriero D, Fabrizi F, Uriel AJ, Park J, Martin P, Dieterich DT. Treatment of dialysis patients with chronic hepatitis C using pegylated interferon and low-dose ribavirin. Int J Artif Organs. 2008; 31(4): 295-302.
25. Deltenre P, Moreno C, Tran A, et al. Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy. Aliment Pharmacol Ther. 2011; 34(4):454-61.
26. Giguere A, Anas A, Nasser T, et al. Treatment of hepatitis C virus infection in patients on maintenance hemodialysis: a single United Arab Emirates center experience. Eur J Intern Med. 2011; 22(6):582-6.
27. Gordon CE, Uhlig K, Schmid CH, Levey AS, Wong JB. Long-term viral negativity after interferon for chronic hepatitis C virus infection in hemodialysis. Clin J Am Soc Nephrol. 2011; 6(9): 2226-34.
28. Li D, Meng J, Yu N, et al. Effect of IFN-gamma and IL-4 levels on the expression of Fas and Bcl-2 in peripheral blood lymphocytes in hemodialysis patients. J Artif Organs. 2011; 14(2): 120-4.
29. Pipili C, Ilonidis G, Cholongitas E. Hepatitis C virus and kidney: a strong association with different clinical aspects. Liver Int. 2011; 31(8): 1071-80.
30. van Leusen R, Adang RP, de Vries RA, et al. Pegylated interferon alfa-2a (40 kD) and ribavirin in haemodialysis patients with chronic hepatitis C. Nephrol Dial Transplant. 2008; 23(2): 721-5.
31. Hadzri MH, Hairul AH, Mustafa MIA, Azril HY. Seroprevalence study of HCV genotypes in two tertiary hospitals and its association with risk factors and current management practice. Med J Malaysia. 2009; 64(Suppl B): 59.
32. Kalinina O, Norder H, Mukomolov S, Magnius LO. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 2002; 76(8): 4034-43.
33. Moreno P, Alvarez M, Lopez L, et al. Evidence of recombination in Hepatitis C Virus populations infecting a hemophiliac patient. Virol J 2009; 6(203):203.
34. Moreno MP, Casane D, Lopez L, Cristina J. Evidence of recombination in quasispecies populations of a Hepatitis C Virus patient undergoing anti-viral therapy. Virol J 2006; 3(87): 87.
35. Sentandreu V, Jimenez-Hernandez N, Torres-Puente M, et al. Evidence of recombination in intrapatient populations of hepatitis C virus. PLoS One 2008; 3(9): e3239.
36. Poccia F, Agrati C. Intrahepatic natural immunity and HCV immunopathogenesis. Cell Death Differ 2003; 10 (Suppl1): S9-S12.
37. Horner SM, Gale M, Jr. Intracellular innate immune cascades and interferon defenses that control hepatitis C virus. J Interferon Cytokine Res 2009; 29(9): 489-98.
38. Ahlers JD, Belyakov IM. Memories that last forever: strategies for optimizing vaccine T-cell memory. Blood 2010; 115(9): 1678-89.
39. Rehermann B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 2009; 119(7): 1745-54.
40. Aoufi Rabih S, Garcia Agudo R. Management of HCV infection in chronic kidney disease. Nefrologia 2011; 31(3): 260-7.
41. Humphreys I, Fleming V, Fabris P, et al. Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infection. J Virol 2009; 83(22): 11456-66.
42. Silva LK, Silva MB, Rodart IF, et al. Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil. Braz J Med Biol Res 2006; 39(5): 595-602.